Home » Topics » BioWorld Science

BioWorld Science
RSS

Researchers report identification of TQ-05310, a novel potent mutant IDH2 inhibitor

Jan. 9, 2020

Carbon dioxide and the brain

Jan. 9, 2020

CureVac reports interim phase I data on prophylactic mRNA-based rabies vaccine CV-7202

Jan. 8, 2020

Dosing begins in phase IIa trial of avasopasem manganese to reduce radiation-induced esophagitis

Jan. 8, 2020

Cerevel starts phase III study of tavapadon in early Parkinson's disease

Jan. 8, 2020

Takeda opens recruitment in phase II study of TAK-079 for generalized myasthenia gravis

Jan. 8, 2020

CStone begins phase III study of CS-1001 for advanced esophageal squamous cell carcinoma

Jan. 8, 2020

New CD7-negative T cells presented as potential treatment for CD7-positive cancer

Jan. 8, 2020

Cobra genome may yield new antivenoms, venom-based drugs

Jan. 8, 2020

Nanchang University identifies antibodies for enterovirus 71 infections

Jan. 8, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...